Found: 49
Select item for more details and to access through your institution.
Perioperative Pembrolizumab Improves Survival in Resected NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 370
- By:
- Publication type:
- Article
Adjuvant Osimertinib Improves Overall Survival in EGFR-Mutated Lung Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 370
- By:
- Publication type:
- Article
Tumor Treating Field Therapy Improves OS in Platinum-Resistant, Metastatic NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 371
- By:
- Publication type:
- Article
Pembrolizumab Does Not Improve Survival in Pretreated, EGFR-Mutated, Metastatic Nonsquamous NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 7, p. 371
- By:
- Publication type:
- Article
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7029, doi. 10.1002/cam4.5502
- By:
- Publication type:
- Article
Oncolytic Viruses and Cancer Immunotherapy.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 1, p. 19, doi. 10.1007/s11912-022-01341-w
- By:
- Publication type:
- Article
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Radiation Therapy and Immunotherapy in Locally Advanced NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 5, p. 288
- By:
- Publication type:
- Article
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.834704
- By:
- Publication type:
- Article
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 52, doi. 10.1016/j.cllc.2021.08.012
- By:
- Publication type:
- Article
Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Safety From a Multisite Retrospective Chart Review in the USA.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 292, doi. 10.1016/j.cllc.2021.02.006
- By:
- Publication type:
- Article
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84731-7
- By:
- Publication type:
- Article
Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 10, p. 2948, doi. 10.1002/ijc.33115
- By:
- Publication type:
- Article
Initial Results from Mobile Low‐Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e777, doi. 10.1634/theoncologist.2019-0802
- By:
- Publication type:
- Article
Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted Therapy for Mutation-Driven Metastatic Non--Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 4, p. 152
- By:
- Publication type:
- Article
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
- Published in:
- Patient, 2019, v. 12, n. 2, p. 223, doi. 10.1007/s40271-018-0327-3
- By:
- Publication type:
- Article
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00262
- By:
- Publication type:
- Article
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 526, doi. 10.1634/theoncologist.2017-0661
- By:
- Publication type:
- Article
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 415, p. 1, doi. 10.1126/scitranslmed.aao4307
- By:
- Publication type:
- Article
Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.
- Published in:
- Lung Cancer: Targets & Therapy, 2017, v. 8, p. 207, doi. 10.2147/LCTT.S138570
- By:
- Publication type:
- Article
The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 3, p. 516, doi. 10.1002/cam4.972
- By:
- Publication type:
- Article
Inhibitory Effect of Bridged Nucleosides on Thermus aquaticus DNA Polymerase and Insight into the Binding Interactions.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147234
- By:
- Publication type:
- Article
Improving the Care of Patients With Stage IB Non--Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 245, doi. 10.1016/j.cllc.2015.02.008
- By:
- Publication type:
- Article
Prognostic Implications of Tumoral Expression of Insulin Like Growth Factors 1 and 2 in Patients With Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 3, p. 213, doi. 10.1016/j.cllc.2013.12.006
- By:
- Publication type:
- Article
Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
New Targets and New Mechanisms in Lung Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 5, p. 1
- By:
- Publication type:
- Article
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 16, p. 3993, doi. 10.1002/cncr.26656
- By:
- Publication type:
- Article
A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 3, p. 537, doi. 10.1002/ijc.26373
- By:
- Publication type:
- Article
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 9, p. 2454, doi. 10.1002/cncr.26492
- By:
- Publication type:
- Article
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 3, p. 228, doi. 10.1093/jnci/djr523
- By:
- Publication type:
- Article
Bronchioloalveolar Carcinoma: a Translational Perspective.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 907
- By:
- Publication type:
- Article
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase 2 Study of Carboplatin, Docetaxel, and Bevacizumab as Frontline Treatment for Advanced Nonsmall – Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 10, p. 2401, doi. 10.1002/cncr.24996
- By:
- Publication type:
- Article
A Phase 2 Study of Cetuximab in Combination With Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 8, p. 1713, doi. 10.1002/cncr.24148
- By:
- Publication type:
- Article
Targeted Therapies in Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 5, p. 922, doi. 10.1002/cncr.24123
- By:
- Publication type:
- Article
Molecular targets for cancer chemoprevention.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Bayesian adaptive design for targeted therapy development in lung cancer -- a step toward personalized medicine.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 181, doi. 10.1177/1740774508091815
- By:
- Publication type:
- Article
Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 7, p. 441, doi. 10.1093/jnci/djj091
- By:
- Publication type:
- Article
Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 11, p. 2449
- By:
- Publication type:
- Article
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 3, p. 561, doi. 10.1002/cncr.21188
- By:
- Publication type:
- Article
An Apple a Day…Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Chemoprevention of Cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2004, v. 54, n. 3, p. 150, doi. 10.3322/canjclin.54.3.150
- By:
- Publication type:
- Article
Immunohistochemical expression of smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-βs.
- Published in:
- Developmental Dynamics, 2001, v. 220, n. 2, p. 141, doi. 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.0.CO;2-4
- By:
- Publication type:
- Article